Modified-release formulations of a bupropion salt

Details for Australian Patent Application No. 2012216590 (hide)

Owner Valeant International (Barbados) SRL

Inventors Massardo, Pietro; Oberegger, Werner; Maes, Paul; Zhou, Fang; Turchetta, Stefano; Jackson, Graham; Saleh, Mohammad Ashty

Agent Davies Collison Cave

Pub. Number AU-A-2012216590

Parent 2006261788

Filing date 31 August 2012

Wipo publication date 20 September 2012

International Classifications

C07C 221/00 Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton

A61K 31/135 - having aromatic rings, e.g. methadone

C07C 225/10 Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

C07C 225/16 Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

Event Publications

13 September 2012 Complete Application Filed

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216590

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216591-System and method for conversion between internet and non-internet based transactions

2012216589-Sclerostin epitopes